All research
Oxytocin 2026-06-17 PubMed

Intranasal oxytocin and multidisciplinary support enable partial breastfeeding in panhypopituitarism

Breastfeeding in panhypopituitarism: a case report, review of the literature, and management checklist.

Background

Lactation is a complex physiological process requiring adequate levels of prolactin for milk production and oxytocin for milk ejection. Panhypopituitarism, a rare endocrine disorder characterized by multiple pituitary hormone deficiencies, often leads to the presumption that breastfeeding is impossible due to impaired prolactin and oxytocin secretion. Current clinical guidance for supporting lactation in this population is extremely limited, leaving a significant gap for women wishing to breastfeed despite their condition.

Study Design

Researchers presented a case study of a 34-year-old pregnant woman in Israel with panhypopituitarism who aimed to breastfeed. Her lactation support protocol included intranasal oxytocin administered before each breastfeed, use of a homemade nursing supplementer, galactagogues, and regular pumping. Concurrently, a literature review identified reports on lactation outcomes in 69 parous women with pituitary hormone deficiencies, examining factors like prior pituitary surgery or radiation therapy potentially linked to breastfeeding success. An exploratory multivariable logistic regression analysis was performed on the collected data.

Results

The case study demonstrated that the woman with panhypopituitarism successfully established and maintained a partial breastfeeding relationship for 6.5 months, supplemented with infant formula. The literature review identified that out of 69 parous women with pituitary hormone deficiencies, 20 were reported to have breastfed. The exploratory multivariable logistic regression analysis suggested that prior radiation therapy was associated with a lower likelihood of breastfeeding success. The use of intranasal oxytocin in the reported case is considered hypothesis-generating, indicating its potential role in supporting milk ejection in this population. No specific adverse events related to the intervention were detailed in the abstract.

The case study patient maintained partial breastfeeding for 6.5 months with the aid of intranasal oxytocin and comprehensive support.

Key Findings

  • A woman with panhypopituitarism achieved partial breastfeeding for 6.5 months with comprehensive support.
  • Lactation support included intranasal oxytocin administered before each breastfeed.
  • Literature review identified 20 of 69 parous women with pituitary deficiency who breastfed.
  • Prior radiation therapy was associated with a lower likelihood of breastfeeding success.
  • Intranasal oxytocin use is hypothesis-generating for supporting lactation in this context.

Why It Matters

This case report and literature review offer crucial insights, suggesting that breastfeeding may be achievable for some women with panhypopituitarism with individualized preparation and multidisciplinary support. It challenges the long-held assumption of impossibility, providing hope and a potential pathway for affected individuals. The successful use of intranasal oxytocin before each feed highlights a specific, actionable intervention that clinicians can consider, potentially improving milk ejection reflex. This finding warrants further research into standardized protocols and could lead to a revised approach to lactation counseling and support for this patient group, moving beyond a blanket recommendation against breastfeeding.


panhypopituitarism breastfeeding lactation oxytocin case-report literature-review
Source: pubmed:42304481 · Ingested 2026-06-17 · Digest: gemini-2.5-flash